| Composition | Voglibose 0.2mg Metformin Hydrochloride 500mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 20×10 |
| Packing | Blister |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
VOGLICOP M 0.2/500 Tablets
VOGLICOP M 0.2/500 is an effective antidiabetic combination tablet formulated to help manage type 2 diabetes efficiently. With a precise 0.2/500 mg dosage, it combines two active ingredients that work synergistically to control blood sugar levels and support stable glycemic management.
This tablet functions by enhancing insulin sensitivity and reducing glucose production in the liver, providing a consistent and reliable effect throughout the day. VOGLICOP M 0.2/500 is ideal for patients seeking a balanced approach to controlling diabetes, particularly when monotherapy alone is insufficient.
Regular use of VOGLICOP M 0.2/500 can help prevent sudden spikes and drops in blood sugar, lowering the risk of long-term diabetes-related complications such as neuropathy, kidney disease, and heart problems. It is prescribed as part of a comprehensive diabetes care plan, alongside proper diet, physical activity, and regular glucose monitoring.
Patients benefit from VOGLICOP M 0.2/500’s consistent efficacy and easy-to-follow dosage, ensuring better adherence to treatment. With its carefully formulated combination, VOGLICOP M 0.2/500 Tablets provide a safe and efficient solution for maintaining healthy blood sugar levels, supporting overall wellness and improving quality of life for individuals with type 2 diabetes.
